Want to join the conversation?
Specialty retailer $FINL posted lower earnings in 1Q17 compared to 1Q16, hurt by higher SG&A expenses. Net income attributable to The Finish Line, Inc. was $9.63MM or $0.23 per diluted share compared to $13.79MM or $0.30 per diluted share in 1Q16. Consolidated net sales were $453.5MM, an increase of 2.3% over last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?